Evolent Health (EVH) Accounts Payables (2015 - 2026)

Evolent Health's Accounts Payables history runs 12 years deep, the most recent figure standing at $63.0 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 8.98% year-over-year to $63.0 million; the TTM figure through Mar 2026 stood at $63.0 million (up 8.98% YoY), while the FY2025 annual figure was $59.8 million, down 37.75% from the prior year.
• Accounts Payables was $63.0 million for Q1 2026 at Evolent Health, up from $59.8 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $96.6 million in Q2 2022 to a low of $39.0 million in Q2 2024.
• Historically, Accounts Payables has averaged $64.3 million across 5 years, with a median of $61.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables surged 142.14% in 2022, then tumbled 49.28% in 2024.
• A 5-year view of Accounts Payables shows it stood at $57.2 million in 2022, then declined by 15.62% to $48.2 million in 2023, then jumped by 99.03% to $96.0 million in 2024, then sank by 37.75% to $59.8 million in 2025, then gained by 5.41% to $63.0 million in 2026.
• The last three Accounts Payables figures came in at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $72.2 million (Q3 2025), per Business Quant data.